BRAFV600E negatively regulates the AKT pathway in melanoma cell lines.
Cross-feedback activation of MAPK and AKT pathways is implicated as a resistance mechanism for cancer therapeutic agents targeting either RAF/MEK or PI3K/AKT/mTOR. It is thus important to have a better understanding of the molecular resistance mechanisms to improve patient survival benefit from thes...
Guardado en:
Autores principales: | Brenden Chen, Christine Tardell, Brian Higgins, Kathryn Packman, John F Boylan, Huifeng Niu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f977105d31fa4f8f9f44e379c7007545 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
IMMUNOHISTOCHEMICAL EXPRESSION OF BRAFV600E IN MELANOMA CASES
por: Muhammad Umer Ch, et al.
Publicado: (2021) -
Overcoming resistance to BRAFV600E inhibition in melanoma by deciphering and targeting personalized protein network alterations
por: S. Vasudevan, et al.
Publicado: (2021) -
SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling
por: Thomas Strub, et al.
Publicado: (2018) -
Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers
por: Yongxing Wu, et al.
Publicado: (2021) -
BRAFV600E induces reversible mitotic arrest in human melanocytes via microrna-mediated suppression of AURKB
por: Andrew S McNeal, et al.
Publicado: (2021)